$HALO news
The latest HALO stock news: headlines, filings, AI summaries and sentiment for $HALO, updated around the clock.
- Morgan Stanley Downgrades Halozyme Therapeutics to Equal Weight
- Halozyme Therapeutics Shares Drop Following Leerink Partners Downgrade
- Halozyme Reports Strong Q3 2026 Results with Significant Revenue Growth and Raised Guidance
- Halozyme Therapeutics Raises 2026 Earnings Guidance Following Strong Q3 Performance
- HALOZYME THERAPEUTICS, INC. - 10-Q Filing
- HALOZYME THERAPEUTICS, INC. - 8-K Filing
- Luxor Technology Secures $16 Million Strategic Investment to Expand AI and Bitcoin Compute Services
- Dutch Court Bans Merck's Injectable Version of Keytruda in Certain European Markets
- Halozyme Wins Dutch Patent Infringement Case Against Merck's Keytruda SC
- HALOZYME THERAPEUTICS, INC. - 8-K Filing
- HALOZYME THERAPEUTICS, INC. - 8-K Filing
- Halozyme Therapeutics Proposes $1.05 Billion in Convertible Senior Notes
- HALOZYME THERAPEUTICS, INC. - 8-K Filing
- Halozyme Therapeutics Announces $1.05 Billion Convertible Notes Offering
- HALOZYME THERAPEUTICS, INC. - 8-K Filing
- Halozyme Reports Record Revenue Growth, Shares Rise Sharply
- Argenx Reports 18 Consecutive Quarters of Sales Growth and Expanding Profitability
- FDA Grants Priority Review for Johnson & Johnson's Expanded Use Application for Rybrevant Faspro
- Recludix Pharma Appoints Athena Countouriotis as Board Chairperson
- Halozyme's Earnings Growth and Institutional Support Drive Share Price to Near All-Time Highs
- Halozyme and Incyte Collaborate on Subcutaneous INCA033989 Using ENHANZE Technology
- Halozyme and Incyte Collaborate on Enhanze Technology for Myeloproliferative Neoplasm Candidate